Gilead Sciences, Inc. (GIS.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 155.3B |
| Enterprise Value | 173.78B |
| P/E Ratio | 16.83 |
| PEG Ratio | 0.3 |
| Price/Sales Ratio | 5.21 |
| Price/Book Ratio | 6.6 |
| Enterprise/Revenue | 5.7 |
| Enterprise/EBITDA | 12.1 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.31 |
| Operating Margin | 0.38 |
AD
Management Effectiveness
| Return On Assets | 0.16 |
| Return On Equity | 0.42 |
Income Statement
| Revenue | 29.45B |
| Revenue/Share | 23.94 |
| Gross Profit | 25.52B |
| EBITDA | 13.58B |
| Net Income | 8.51B |
| Diluted EPS | 6.78 |
Balance Sheet
| Total Cash | 9.78B |
| Total Cash/Share | 7.9 |
| Total Debt | 22.09B |
| Total Debt/Equity | 0.94 |
| Current Ratio | 1.97 |
| Book Value Per Share | 18.87 |
Price History
| 52-Week Change | 19.45 |
| 52-Week High | 132 |
| 52-Week Low | 89.96 |
| Moving Average 50 Days | 112.6 |
| Moving Average 200 Days | 111.45 |
Statistics
| Average Volume | 951 |
| Shares Outstanding | 1.24B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.22 |
| Trailing Annual Dividend Yield | 2.58 |
| Payout Ratio | 0.44 |
| Last Split Factor | 2:1 |
| Last Split Date | January 28, 2013 |
AD
